Business Wire

CrowdStrike Introduces New Automated Threat Analysis Solution to Deliver Predictive Security

Del

CrowdStrike® Inc., the leader in cloud-delivered endpoint protection, today announced that it has expanded the capabilities of the CrowdStrike Falcon® platform by introducing a new threat analysis subscription module, CrowdStrike Falcon X™.

In today's threat environment, it is critical to add predictive security controls by learning from your encounters with cyber threat actors. However, most security teams lack the resources or the expertise to effectively adopt this emerging approach. As a result, they are stuck in a reactive state and can’t get ahead of future threats. CrowdStrike Falcon X solves this problem by automating threat analysis and delivering customized and actionable intelligence so that organizations can implement proactive defenses.

Built on the CrowdStrike Falcon platform, CrowdStrike Falcon X brings endpoint protection to the next level by combining malware sandboxing, malware search and threat intelligence into an integrated solution that can perform comprehensive threat analysis in seconds instead of hours or days. The output of this analysis is a unique combination of customized indicators of compromise (IOCs) and threat intelligence designed to help prevent against threats your organization faces now and in the future. Falcon X is the only solution that produces IOCs for both the threat that was actually encountered in your organization and all of its known variants, and immediately shares them with other security tools like firewalls, gateways and security orchestration tools via API. CrowdStrike Falcon X also provides integrated threat intelligence alongside its security alerts to accelerate incident research, streamline the investigative process and drive better security responses.

With this Spring Platform release, CrowdStrike empowers customers of all sizes to better understand the threats they face and improve the efficacy of their other security investments with actionable and customized intelligence. CrowdStrike Falcon X allows customers to finally pivot from a reactive security posture to a proactive one, mitigating their risk exposure and enhancing their ability to stop breaches.

“Most incident response teams have to manually analyze the threats they face with limited visibility into the targeted threat intelligence behind them. With CrowdStrike Falcon X, we elevate customers’ abilities to perform better analysis when a threat is detected and correlate it with strategic and tactical intelligence quickly, cutting down investigation time from hours and even days to seconds. Through this automation, we help smaller teams achieve a level of protection that would normally be out of reach, and we help larger teams make each of their analysts more effective. Falcon X provides all security teams with more comprehensive threat analysis to inform effective, prioritized response options, making remediation efforts more strategic and efficient,” said Dmitri Alperovitch, CrowdStrike’s co-founder and chief technology officer.

CrowdStrike Falcon X stands out with the following capabilities:

  • Automatic Threat Analysis — All files quarantined by CrowdStrike Falcon endpoint protection are automatically investigated by Falcon X. This automation drives breakthrough efficiency gains for security operations teams, elevates the capabilities of all security analysts and unlocks critical security functionality for organizations without a SOC.
  • Malware Analysis — Falcon X enables in-depth analysis of unknown and zero-day threats that goes far beyond traditional approaches. Powered by the Falcon Sandbox, it employs a unique combination of static, dynamic and fine-grained memory analysis to quickly identify the evasive threats other solutions miss.
  • Malware Search — Connects the dots between the malware found on your endpoints and related campaigns, malware families or threat actors. Falcon X searches CrowdStrike Falcon Search Engine, the industry's largest malware search engine for related samples and within seconds expands the analysis to include all files and variants, leading to a deeper understanding of the attack and an expanded set of IOCs to defend against future attacks.
  • Threat Intelligence Actor attribution exposes the motivation and the tools, techniques and procedures (TTPs) of the attacker. Practical guidance is provided to prescribe proactive steps against future attacks and stop actors in their tracks.
  • Customized Intelligence CrowdStrike Falcon X automatically produces intelligence specifically tailored for the threats you encounter in your environment. Customized IOCs are immediately shared with other security tools via API, streamlining and automating the protection workflow. Cyber threat intelligence related to the encountered attack is displayed alongside the alert, making it quick and easy for analysts to understand the threat and take action.

“CrowdStrike technology has proven to be a key security resource to help our team analyze cyber threats and prioritize the most critical malicious behavior for faster remediation,” said Edward Ganom, chief information security officer at the Commercial Bank in Qatar. “CrowdStrike Falcon has proven time and time again its ability to accelerate the threat detection and response process and integrate actionable intelligence to better protect our environment against cyberattacks.”

According to a Gartner Strategic Planning Assumption, by 2021, at least one company will publicly acknowledge a $1 billion revenue impact from a business outage resulting from a malware/ransomware attack. Gartner states, “To counteract this growth, companies will need not only to increase their proactive defenses, but also to speed up their time to react, repair damaged data and return systems to operational states. Holistic attack detection platforms that analyze data from endpoints, internal infrastructure and external resources become vital to decrease the time to detect and recover.”*

The CrowdStrike Falcon platform leverages machine learning and behavioral analytics, trained on processing over 100 billion security events a day, to enable reliable prevention, detection, mitigation and response to all threats, including malware-free intrusions. With the launch of Falcon X, customers can now prevent, detect, respond to and predict cyberthreats, all through one cloud-native platform.

1.Gartner, “Predicts 2018: Security and Risk Management Programs,” Rob McMillan, Jeffrey Wheatman, et al., 16 November 2017.

For more information about the CrowdStrike Spring Platform launch, read a blog by George Kurtz, CrowdStrike’s CEO, here.

Visit CrowdStrike during the RSA Conference 2018 at booth #941 Moscone South to see presentations and demos and meet with CrowdStrike security experts.

About CrowdStrike®

CrowdStrike is the leader in cloud-delivered endpoint protection. Leveraging artificial intelligence (AI), the CrowdStrike Falcon® platform offers instant visibility and protection across the enterprise and prevents attacks on endpoints on or off the network. CrowdStrike Falcon deploys in minutes to deliver actionable intelligence and real-time protection from Day One. It seamlessly unifies next-generation AV with best-in-class endpoint detection and response, backed by 24/7 managed hunting. Its cloud infrastructure and single-agent architecture take away complexity and add scalability, manageability, and speed.

CrowdStrike Falcon protects customers against all cyberattack types, using sophisticated signatureless AI and Indicator-of-Attack (IOA) based threat prevention to stop known and unknown threats in real time. Powered by the CrowdStrike Threat Graph™, Falcon instantly correlates over 100 billion security events a day from across the globe to immediately prevent and detect threats.

There’s much more to the story of how Falcon has redefined endpoint protection but there’s only one thing to remember about CrowdStrike: We stop breaches.

You can gain full access to CrowdStrike Falcon Prevent™ by starting your free trial here.

Learn more: https://www.crowdstrike.com/
Follow us: Blog | Twitter

© 2018 CrowdStrike, Inc. All rights reserved. CrowdStrike®, CrowdStrike Falcon®, CrowdStrike Threat Graph™, CrowdStrike Falcon Prevent™, Falcon Prevent™, CrowdStrike Falcon Insight™, Falcon Insight™, CrowdStrike Falcon Discover™, Falcon Discover™, CrowdStrike Falcon Intelligence™, Falcon Intelligence™, CrowdStrike Falcon DNS™, Falcon DNS™, CrowdStrike Falcon OverWatch™, Falcon OverWatch™, CrowdStrike Falcon Spotlight™ and Falcon Spotlight™ are among the trademarks of CrowdStrike, Inc. Other brands may be third-party trademarks.

Contact information

CrowdStrike, Inc.
Ilina Cashiola, 202-340-0517
Ilina.cashiola@crowdstrike.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Heidelberg Engineering Announces the CE-Marking of ANTERION21.9.2018 16:41Pressemelding

Heidelberg Engineering, the leader in diagnostic imaging known for the internationally-acclaimed SPECTRALIS ® retina and glaucoma platform, announces the CE-marking of ANTERION ® – an innovative platform designed to transform anterior segment diagnostics and workflow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005442/en/ The new Heidelberg Engineering ANTERION® provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. (Graphic: Business Wire) The new ANTERION provides the most important anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solution that brings together corneal topography and tomography, anterior segment metrics, axial length measurement and IOL calculation to transform the day-to-day routine of busy practices and clinics. Heidelberg Engineering has leveraged its core OCT technolo

Florian Winterstein Becomes New CEO of Jedox21.9.2018 15:46Pressemelding

The supervisory board of Jedox AG, a leading vendor of business intelligence and enterprise planning software, has appointed Florian Winterstein as Chief Executive Officer (CEO) effective October 2, 2018. This nomination will support Jedox’s international growth and a new development phase initiated by its latest fund raising in April 2018 with Iris Capital, eCAPITAL entrepreneurial Partners AG and Wecken & Cie. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180921005416/en/ Florian Winterstein (Photo: Business Wire) With 25 years of experience in strategy consulting and leadership in software and service organizations, Winterstein brings to the company a valuable combination of expertise in cloud solutions, business development, and value creation for customers and partners. As former Chief Strategy Officer of BravoSolution, he positioned the software-as-a-service company as trendsetting digitalization partner, extending it

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib21.9.2018 13:30Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG® (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food. The randomized, global Phase 2 ALTA trial was designed to investigate the efficacy and safety of ALUNBRIG in patients with locally advanced or metastatic ALK+

Asda Selects HCL Technologies to Help Drive IT Transformation21.9.2018 12:16Pressemelding

HCL Technologies (HCL), a leading global technology company, today announced that it has been selected to help drive IT transformation at the UK’s third-largest grocery retailer, Asda. The three-year application services contract will see HCL transform Asda’s IT Application Services with a new DevOps delivery model to drive data and analytics and support back-office applications through the full lifecycle of development, testing and support. HCL will also build a central data management platform to enable Asda to improve its insight and analytics capabilities. Asda operates more than 600 stores across the UK, employing over 135,000 people. Asda wanted to adopt a more agile approach towards application development and testing. This would allow the company to respond faster to business requirements and reduce time to market, while driving better user experience and satisfaction. HCL was selected due to its extensive expertise in successfully delivering similar large scale IT transformati

Ipsen Receives Positive CHMP Opinion for Cabometyx® (Cabozantinib) for the Second-line Treatment of Patients with Hepatocellular Carcinoma (HCC)21.9.2018 05:30Pressemelding

Regulatory News: Ipsen (Euronext:IPN; ADR:IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), provided a positive opinion for Cabometyx® (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have been previously treated with sorafenib. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for the European Union (EU). Alexandre Lebeaut, MD, Executive Vice President, R&D and Chief Scientific Officer, Ipsen, said: “The global burden of liver cancer is increasing and despite the recent introduction of new agents, it remains the second leading cause of cancer mortality worldwide. Following today’s positive CHMP opinion and if approved by the European Commission, Cabometyx ® as monotherapy will give patients with HCC a much-needed new oral therapeutic option.” Dr Lorenza Rimassa,

Quanergy Selected as Exclusive LiDAR Partner for VRCO21.9.2018 05:00Pressemelding

Quanergy Systems, Inc., a global leader in the design and development of solid state LiDAR sensors and smart sensing solutions, and VRCO, designer and manufacturer of the luxury high-end e-VTOL (electric Vertical Take-Off and Landing) craft, the NeoXcraft XP2, today announced that VRCO will exclusively use Quanergy’s S3 solid state LiDAR sensors in the testing and market release versions of the aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920006036/en/ VRCO NeoXcraft XP2 with Quanergy S3 LiDAR Sensor (Graphic: Business Wire) The NeoXcraft XP2, which VRCO and the University of Derby unveiled in late 2017 and intend to launch in 2020, is a two-passenger e-VTOL high-speed land, air, and water capable craft. The craft can scan and memorize take-off locations and store the data for use on the next approach to the same location. Quanergy’s innovative S3 solid state LiDAR sensor will be used for downward and forward